Drug Insight: selective agonists and antagonists of the glucocorticoid receptor

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Nature Clinical Practice Endocrinology &Metabolism

• Publication date

  2008-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/ncpendmet0745PMID 18212811
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glucocorticoid-induced osteoporosis: pathophysiology and therapy

  2007cited by this paper
• Folic acid prevents and partially reverses glucocorticoid-induced hypertension in the rat.

  2007cited by this paper
• Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series.

  2006cited by this paper
• Patterns of cardiovascular risk in rheumatoid arthritis

  2006cited by this paper
• 11β-Hydroxysteroid dehydrogenase type 2 protects the neonatal cerebellum from deleterious effects of glucocorticoids

  2006cited by this paper
• Steroid receptor coactivator (SRC)-1 and SRC-3 differentially modulate tissue-specific activation functions of the progesterone receptor.

  2006cited by this paper
• Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells.

  2006cited by this paper
• 11beta-Hydroxysteroid dehydrogenase type 2 protects the neonatal cerebellum from deleterious effects of glucocorticoids.

  2006cited by this paper
• Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity.

  2006cited by this paper
• Genetic manipulation of 11beta-hydroxysteroid dehydrogenases in mice.

  2005cited by this paper
• Transcriptional regulation by steroid receptor coactivator phosphorylation.

  2005cited by this paper
• Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity.

  2005cited by this paper
• A life-long search for the molecular pathways of steroid hormone action.

  2005cited by this paper
• Mice lacking the amplified in breast cancer 1/steroid receptor coactivator-3 are resistant to chemical carcinogen-induced mammary tumorigenesis.

  2005cited by this paper
• A fully dissociated compound of plant origin for inflammatory gene repression.

  2005cited by this paper
• The search for safer glucocorticoid receptor ligands.

  2005cited by this paper
• Dynamic Cell Type Specificity of SRC-1 Coactivator in Modulating Uterine Progesterone Receptor Function in Mice

  2005cited by this paper
• Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes.

  2005cited by this paper
• Dual Functions of the Steroid Hormone Receptor Coactivator 3 in Modulating Resistance to Thyroid Hormone

  2005cited by this paper
• Nuclear Hormone Receptor Coregulator GRIP1 Suppresses, whereas SRC1A and p/CIP Coactivate, by Domain-specific Binding of MyoD*♦

  2005cited by this paper
• Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes.

  2005cited by this paper
• Perinatal Corticosteroids: A Review of Research Part I: Antenatal Administration

  2004cited by this paper
• Is 11beta-hydroxysteroid dehydrogenase type 1 a good therapeutic target for blockade of glucocorticoid actions?

  2004cited by this paper
• 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.

  2004cited by this paper
• Results of a Search for the Mechanisms of Steroid Receptor Regulation of Gene Expression

  2004cited by this paper
• 11β-hydroxysteroid dehydrogenases: changing glucocorticoid action

  2004cited by this paper
• Selective Estrogen Receptor Modulators 4-Hydroxytamoxifen and Raloxifene Impact the Stability and Function of SRC-1 and SRC-3 Coactivator Proteins

  2004cited by this paper
• Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes.

  2004cited by this paper
• Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription?

  2004cited by this paper
• The Origin and Functions of Multiple Human Glucocorticoid Receptor Isoforms

  2004cited by this paper
• Rapid Glucocorticoid Receptor Exchange at a Promoter Is Coupled to Transcription and Regulated by Chaperones and Proteasomes

  2004cited by this paper
• Taking Glucocorticoids by Prescription Is Associated with Subsequent Cardiovascular Disease

  2004cited by this paper
• Glucocorticoid Ligands Specify Different Interactions with NF-κB by Allosteric Effects on the Glucocorticoid Receptor DNA Binding Domain*

  2004cited by this paper
• The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain RU-486 INDUCES A TRANSCONFORMATION THAT LEADS TO ACTIVE ANTAGONISM*

  2003cited by this paper
• Hierarchical Affinities and a Bipartite Interaction Model for Estrogen Receptor Isoforms and Full-length Steroid Receptor Coactivator (SRC/p160) Family Members*

  2003cited by this paper
• Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor

  2003cited by this paper
• Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.

  2003cited by this paper
• The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain

  2003cited by this paper
• Review article: medical treatment of moderate to severe Crohn's disease.

  2003cited by this paper
• A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects.

  2003cited by this paper
• Medical treatment of moderate to severe Crohn's disease

  2003cited by this paper
• Tissue-specific Cushing's syndrome, 11beta-hydroxysteroid dehydrogenases and the redefinition of corticosteroid hormone action.

  2003cited by this paper
• Interactions between GH, IGF-I, Glucocorticoids, and Thyroid Hormones during Skeletal Growth

  2002cited by this paper
• Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition.

  2002cited by this paper
• Rapid nontranscriptional activation of endothelial nitric oxide synthase mediates increased cerebral blood flow and stroke protection by corticosteroids.

  2002cited by this paper
• Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase

  2002cited by this paper
• Cell type-dependent divergence of transactivation by glucocorticoid receptor ligand.

  2002cited by this paper
• Molecular Determinants for the Tissue Specificity of SERMs

  2002cited by this paper
• 11β-HYDROXYSTEROID DEHYDROGENASES: A NOVEL CONTROL OF GLUCOCORTICOID ACTION IN THE BRAIN

  2002cited by this paper
• Different glucocorticoids vary in their genomic and non‐genomic mechanism of action in A549 cells

  2002cited by this paper
• Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts

  2002cited by this paper
• New Glucocorticosteroids with an improved therapeutic ratio?

  2001cited by this paper
• Therapeutic Benefit of a Dissociated Glucocorticoid and the Relevance of In Vitro Separation of Transrepression from Transactivation Activity

  2001cited by this paper
• A review of the pharmacology and pharmacokinetics of inhaled fluticasone propionate and mometasone furoate.

  2001cited by this paper
• Corepressors and nuclear hormone receptor function.

  2001cited by this paper
• The glucocorticoid receptor interacting protein 1 (GRIP1) localizes in discrete nuclear foci that associate with ND10 bodies and are enriched in components of the 26S proteasome.

  2001cited by this paper
• Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor

  2001cited by this paper
• Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor.

  2000cited by this paper
• Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription.

  2000cited by this paper
• Ligand-dependent regulation of vascular endothelial growth factor and erythropoietin expression by a plasmid-based autoinducible GeneSwitch system.

  2000cited by this paper
• Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions.

  1999cited by this paper
• DNA binding of the glucocorticoid receptor is not essential for survival.

  1998cited by this paper
• A role for brain glucocorticoid receptors in contextual fear conditioning: dependence upon training intensity.

  1998cited by this paper
• Correlational relationship between shock intensity and corticosterone secretion on the establishment and subsequent expression of contextual fear conditioning.

  1998cited by this paper
• IκBα‐independent downregulation of NF‐κB activity by glucocorticoid receptor

  1997cited by this paper
• Glucocorticoid-Dependent Transcriptional Repression of the Osteocalcin Gene by Competitive Binding at the TATA Box

  1997cited by this paper
• Glucocorticoids as Counterregulatory Hormones of Leptin: Toward an Understanding of Leptin Resistance

  1997cited by this paper
• Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo.

  1997cited by this paper
• Glucocorticoid receptor structure and function in glucocorticoid-resistant small cell lung carcinoma cells.

  1996cited by this paper
• Deflazacort. A review of its pharmacological properties and therapeutic efficacy.

  1995cited by this paper
• Immunosuppression by Glucocorticoids: Inhibition of NF-κB Activity Through Induction of IκB Synthesis

  1995cited by this paper
• Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis.

  1995cited by this paper
• Increased evening activation of the hypothalamic-pituitary-adrenal axis in depressed patients.

  1994cited by this paper
• Novel glucocorticoid receptor complex with DNA element of the hormone‐repressed POMC gene.

  1993cited by this paper
• Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.

  1992cited by this paper
• Dexamethasone does not inhibit the release of mediators from human mast cells residing in airway, intestine, or skin.

  1989cited by this paper
• Hormone-mediated repression: a negative glucocorticoid response element from the bovine prolactin gene.

  1988cited by this paper
• Receptor-mediated effects of glucocorticoids on inflammation: enhancement of the inflammatory response with a glucocorticoid antagonist.

  1988cited by this paper
• Effects of glucocorticoids on carbohydrate metabolism.

  1988cited by this paper
• Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor.

  1987cited by this paper
• Oral glucocorticoids and their complications. A review.

  1986cited by this paper
• A comparison of the acute inflammatory response in adrenalectomised and sham‐operated rats

  1986cited by this paper
• Effects of in vitro corticosteroids on B cell activation, proliferation, and differentiation.

  1985cited by this paper
• Glucocorticoid actions on lymphoid tissue and the immune system: physiologic and therapeutic implications.

  1984cited by this paper
• Beclomethasone dipropionate aerosol in treatment of perennial and seasonal rhinitis: a review of five years' experience.

  1977cited by this paper
• Genetic manipulation

  1976cited by this paper
• Steric course of reactions of steroids

  1950cited by this paper
• Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions.

  1950cited by this paper

• Occurrence, Fate and Mass Balance of Sixty-Eight Natural and Synthetic Glucocorticoids in a Municipal Wastewater Treatment Plant

  2026cites this paper
• Risk factors for fistulizing disease of the pouch after ileal pouch-Anal anastomosis for ulcerative colitis.

  2026cites this paper
• Elucidation of the plant progesterone biosynthetic pathway and its application in a yeast cell factory.

  2025cites this paper
• Merging Natural Product Structures with Pharmaceutical Leads: Unnatural Enantiomers of Estranes as Glucocorticoid Receptor Modulators That Suppress TNF-α and IL-6 Release.

  2024cites this paper
• 5α‐Tetrahydrocorticosterone: A topical anti‐inflammatory glucocorticoid with an improved therapeutic index in a murine model of dermatitis

  2023cites this paper
• De novo progesterone synthesis in plants

  2023cites this paper
• Nuclear receptor ligand screening in an iPSC-derived in vitro blood–brain barrier model identifies new contributors to leptin transport

  2022cites this paper
• In vitro modeling of glucocorticoid mechanisms in stress-related mental disorders: Current challenges and future perspectives

  2022cites this paper
• The maternal-placental-fetal interface: Adaptations of the HPA axis and immune mediators following maternal stress and prenatal alcohol exposure

  2022cites this paper
• Molecular docking and dynamic simulation approach to decipher steroidal sapogenins (genus Trillium) derived agonists for glucocorticoid receptor

  2021cites this paper
• Core genes involved in the regulation of acute lung injury and their association with COVID-19 and tumor progression: A bioinformatics and experimental study

  2021cites this paper
• Excipient of paclitaxel induces metabolic dysregulation and unfolded protein response

  2021cites this paper
• A Case of Glucocorticoid Hypersensitivity Syndrome Associated With Underlying Rubella Virus Infection

  2021cites this paper
• Artemisinin Reverses Glucocorticoid-Induced Injury in Bone Marrow-Derived Mesenchymal Stem Cells through Regulation of ERK1/2-CREB Signaling Pathway

  2021cites this paper
• Aggregation and analysis of secondary pharmacology data from investigational new drug submissions at the US Food and Drug Administration.

  2021cites this paper
• Application of glucocorticoids in patients with novel coronavirus infection: From bench to bedside

  2020cites this paper
• Primary Generalized Glucocorticoid Hypersensitivity Treated with Mifepristone: A Case Report

  2020cites this paper
• Baicalein Is a Phytohormone that Signals Through the Progesterone and Glucocorticoid Receptors

  2020cites this paper
• Quantitative Predictions for Molecular Initiating Events using 3D Quantitative Structure-Activity Relationships.

  2020cites this paper
• Therapeutic implications of hypothalamic-pituitary-adrenal-axis modulation in Alzheimer's disease: A narrative review of pharmacological and lifestyle interventions.

  2020cites this paper
• Effect of Long-term Use of Steroidal Anti-inflammatory Drugs on the Periodontal State: A Review

  2020cites this paper
• A patent review of anticancer glucocorticoid receptor modulators (2014-present)

  2020cites this paper
• Glucocorticoids Shape Macrophage Phenotype for Tissue Repair

  2019cites this paper
• Use of In Vitro Models in Drug Development and Issue Resolution

  2019cites this paper
• Steroids for Scars

  2019cites this paper
• Identification and circumvention of bottlenecks in CYP21A2‐mediated premedrol production using recombinant Escherichia coli

  2019cites this paper
• Acetylation of Hsp90 reverses dexamethasone-mediated inhibition of insulin secretion.

  2019cites this paper
• Topical Corticosteroids: Pharmacology

  2018cites this paper
• CORTICOSTEROIDS - ASSETS AND LIABILITIES ON PERIODONTIUM

  2018cites this paper
• Nuclear Receptors Database Including Negative Data (NR-DBIND): A Database Dedicated to Nuclear Receptors Binding Data Including Negative Data and Pharmacological Profile.

  2018cites this paper
• Non-coding RNAs in beta cell insulin secretion - emerging players in Type 2 Diabetes pathogenesis

  2017cites this paper
• Long-acting (cid:2) 2 -agonists promote glucocorticoid-mediated repression of NF- (cid:3) B by enhancing expression of the feedback regulator TNFAIP3

  2017cites this paper
• Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study

  2017cites this paper
• SKOV3 cells containing a truncated ARID1a protein have a restricted genome-wide response to glucocorticoids.

  2017cites this paper
• Selective Glucocorticoid Receptor Properties of GSK866 Analogs with Cysteine Reactive Warheads

  2017cites this paper
• Obesity, Cortisol Excess, and the Hypothalamic–Pituitary–Adrenal Axis

  2017cites this paper
• Modelling the glucocorticoid receptor dimerisation cycle

  2017cites this paper
• Modulation of glucocorticoid action in vivo : role of lipid rafts and clocks

  2017influential citation
• The effect of environmental stress and selective glucocorticoid receptor modulators on chicken and human leukaemia cells

  2017cites this paper
• Cistrome-based Cooperation between Airway Epithelial Glucocorticoid Receptor and NF-κB Orchestrates Anti-inflammatory Effects*

  2016cites this paper
• Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments

  2016cites this paper
• An abnormality in glucocorticoid receptor expression differentiates steroid responders from nonresponders in keloid disease

  2015cites this paper
• Emerging drugs for Cushing’s disease

  2015cites this paper
• Current trends in postsurgical management of ocular inflammation following cataract surgery

  2015cites this paper
• Glucocorticoid receptor function in health and disease

  2015cites this paper
• Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds.

  2015cites this paper
• Cationic lipid-conjugated dexamethasone as a selective antitumor agent.

  2014cites this paper
• The Methyltransferase WBSCR22/Merm1 Enhances Glucocorticoid Receptor Function and Is Regulated in Lung Inflammation and Cancer

  2014cites this paper
• Discovery of acylurea isosteres of 2-acylaminothiadiazole in the azaxanthene series of glucocorticoid receptor agonists.

  2014cites this paper
• Context-dependent Cooperation Between NF-kB and the Glucocorticoid Receptor at a TNFAIP3 Enhancer: A Mechanism to Maintain Negative Feedback Control of Inflammation*

  2014cites this paper
• Discovery of a potent and dissociated non-steroidal glucocorticoid receptor agonist containing an alkyl carbinol pharmacophore.

  2014cites this paper
• Improvement of spinal non-viral IL-10 gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain

  2014cites this paper
• The hit-to-lead optimization of 1,2,3,4,4a,9a-hexahydro-1H- xanthenes as glucocorticoid receptor antagonists

  2014cites this paper
• Context-dependent Cooperation between Nuclear Factor κB (NF-κB) and the Glucocorticoid Receptor at a TNFAIP3 Intronic Enhancer

  2014cites this paper
• Application of systems biology to dissect glucocorticoid receptor function

  2013cites this paper
• A ligand-specific kinetic switch regulates glucocorticoid receptor trafficking and function

  2013cites this paper
• Local blockade of glucocorticoid activation reverses stress‐ and glucocorticoid‐induced delays in cutaneous wound healing

  2013cites this paper
• Milk fat globule-EGF factor 8 mediates the enhancement of apoptotic cell clearance by glucocorticoids

  2013cites this paper
• Mechanisms of Altered Glucocorticoid Sensitivity

  2013cites this paper
• Glucocorticoid hypersensitivity syndrome--a case report.

  2012cites this paper
• Discovery of liver selective non-steroidal glucocorticoid receptor antagonist as novel antidiabetic agents.

  2012cites this paper
• Current concepts in glucocorticoid resistance.

  2012cites this paper
• Understanding the side effects of glucocorticoid therapy: shining a light on a drug everyone thinks they know

  2012cites this paper
• REVIEW 5 a -Reduced glucocorticoids: a story of natural selection

  2012cites this paper
• Implications of glucocorticoid therapy in idiopathic inflammatory myopathies

  2012cites this paper
• Reducing safety-related drug attrition: the use of in vitro pharmacological profiling

  2012cites this paper
• Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor.

  2012cites this paper
• The mouse as a model to investigate sex steroid metabolism in the normal and pathological prostate.

  2012cites this paper
• The use of the glucocorticoid receptor antagonist mifepristone in Cushing's syndrome

  2012cites this paper
• ION CHANNELS

  2011cites this paper
• Cell Cycle Phase Regulates Glucocorticoid Receptor Function

  2011cites this paper
• Clinical and epidemiological research

  2011cites this paper
• Guide to Receptors and Channels (GRAC), 5th edition

  2011cites this paper
• Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis

  2011cites this paper
• ENZYMES

  2011cites this paper
• Consultants

  2011cites this paper
• TRANSPORTERS

  2011cites this paper
• Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist

  2011cites this paper
• Clinical and epidemiological research

  2011cites this paper
• CATALYTIC RECEPTORS

  2011cites this paper
• Oncolytic viruses as experimental treatments for malignant gliomas: using a scourge to treat a devil.

  2010cites this paper
• Oncostatin M is a novel glucocorticoid-dependent neuroinflammatory factor that enhances oligodendrocyte precursor cell activity in demyelinated sites.

  2010cites this paper
• Topical corticosteroids in psoriasis: strategies for improving safety

  2010cites this paper
• Glucocorticoid's pharmacology: past, present and future.

  2010cites this paper
• Nonsteroidal dissociated glucocorticoid agonists containing azaindoles as steroid A-ring mimetics.

  2010cites this paper
• Medical Treatment of Cushing’s Syndrome: Glucocorticoid Receptor Antagonists and Mifepristone

  2010cites this paper
• Characterization of a novel non-steroidal glucocorticoid receptor antagonist.

  2010cites this paper
• The role of glucocorticoids for spiral ganglion neuron survival.

  2009cites this paper
• Body composition and bone mineral density in rheumatoid arthritis : Influence of inflammation and treatment with glucocorticoids and TNF-blocking agents

  2009cites this paper
• Iatrogenic Cushing syndrome caused by ocular glucocorticoids in a child

  2009cites this paper
• Regulation of innate immune responses in the brain

  2009cites this paper
• Cortisol-Induced Masculinization: Does Thermal Stress Affect Gonadal Fate in Pejerrey, a Teleost Fish with Temperature-Dependent Sex Determination?

  2009cites this paper
• Guide to Receptors and Channels (GRAC), 4th edition

  2009cites this paper
• NUCLEAR RECEPTORS

  2009cites this paper
• Aryl aminopyrazole benzamides as oral non-steroidal selective glucocorticoid receptor agonists.

  2009cites this paper
• Steroid hormone binding receptors: application of homology modeling, induced fit docking, and molecular dynamics to study structure-function relationships.

  2009cites this paper
• Hypoxia and glucocorticoid signaling converge to regulate macrophage migration inhibitory factor gene expression.

  2009cites this paper
• The first X-ray crystal structure of the glucocorticoid receptor bound to a non-steroidal agonist.

  2008cites this paper
• Endogenous and exogenous glucocorticoid effects in a model of allergic airway inflammation.

  2008cites this paper